U.S. Mortgage Finance Stock News

In recent months, Evolv Technologies Holdings reported strong quarterly results, including a 57% year-over-year revenue increase, positive adjusted EBITDA, and raised full-year 2025 revenue guidance, while CEO John Kedzierski sold 74,322 shares after exercising 207,000 options primarily to cover tax obligations. Despite the insider sale reducing his direct ownership by about 34.57%, Kedzierski still retains a significant stake, aligning leadership incentives with shareholders as Evolv’s...

Axcelis Technologies overview and recent performance context Axcelis Technologies (ACLS) has attracted attention after a period of mixed financial trends, with annual revenue growth of 2.99% and a 13.63% decline in net income, prompting investors to reassess the current share price of $95.72. See our latest analysis for Axcelis Technologies. Recent trading has been positive, with a 1 month share price return of 11.81% and a 90 day share price return of 14.27%. The 1 year total shareholder...

UWM Holdings (UWMC) is back in focus after President Donald Trump announced a US$200b federal program to buy mortgage backed securities. The move is aimed at influencing mortgage rates outside the Federal Reserve’s actions. See our latest analysis for UWM Holdings. The news-driven jump in UWM’s share price sits against mixed recent performance, with a 20% 7 day share price return, a 21.09% year to date share price return, and a 68.11% 3 year total shareholder return. This suggests momentum...

Citizens’ new coverage of PulteGroup (PHM), paired with recent federal limits on institutional single family home purchases, has pushed the homebuilder into focus for investors tracking policy sensitive housing names. See our latest analysis for PulteGroup. The recent federal cap on institutional single family purchases and Citizens’ upbeat initiation have arrived alongside an 11.15% 7 day share price return and a 23.22% 1 year total shareholder return. This suggests momentum has recently...

Asset sales and analyst sentiment put Federal Realty Investment Trust (FRT) in focus Federal Realty Investment Trust (FRT) is drawing fresh attention as it raises funds through asset sales to support future growth, while analysts maintain a moderate buy rating that keeps sentiment broadly constructive around the stock. See our latest analysis for Federal Realty Investment Trust. The share price, which last closed at US$101.80, has been edging higher recently, with a 90 day share price return...

ImmunityBio’s ANKTIVA lung cancer data and what it means for investors ImmunityBio (IBRX) reported statistically significant immune restoration and a link between lymphocyte recovery and survival in non small cell lung cancer from its ANKTIVA clinical program, based on the QUILT-2.023 and QUILT-3.055 studies. The company highlighted results across 151 checkpoint experienced patients who had progressed after standard treatments, describing these data as foundational safety and efficacy...

CAVA Group, Inc. recently appointed veteran operator Doug Thompson as Chief Operations Officer, effective March 2, 2026, and earlier this month rolled out its largest-ever nationwide Mediterranean menu update, featuring new high-protein bowls, sides, drinks, and the return of white sweet potato. Together, the leadership hire and expanded menu highlight CAVA’s emphasis on sharpening restaurant operations while broadening its offering to keep guests engaged as it scales. We’ll now examine how...

Penske Automotive Group, Inc.'s ( NYSE:PAG ) price-to-earnings (or "P/E") ratio of 11.5x might make it look like a buy...

With no single headline event driving attention to McGraw Hill (MH) today, recent trading performance is doing the talking, including a past 3 months return of about 26% against a softer month and year to date. See our latest analysis for McGraw Hill. Short term, momentum has cooled with a 7 day share price return of 5.0% and a 30 day share price return of 7.7%. However, the 90 day share price return of 25.6% still points to building interest around McGraw Hill at a share price of $15.83. If...

In early January 2026, Canadian Solar Inc. completed a US$200,000,000 private offering of 3.25% convertible senior unsecured notes due January 15, 2031, issued at 100% of principal and structured as callable Eurodollar Eurobonds under Rule 144A. The company plans to use the proceeds to fund U.S. manufacturing and the value chain supporting solar and battery energy storage solutions, underlining its push deeper into higher-value segments of the clean energy market. We’ll now examine how this...

Event context and recent share performance Haemonetics (HAE) has drawn investor interest after recent price moves, with the stock last closing at $82.92. Short term returns are slightly positive, while the past month shows a small decline. See our latest analysis for Haemonetics. Recent trading has been relatively steady, with a 1 day share price return of 1.08% and a 7 day share price return of 0.99% at a last close of $82.92. That sits alongside a 90 day share price return of 66.64%, a year...

Rithm Capital recently announced a fixed-rate junior senior cumulative redeemable preferred stock offering, adding a new layer of fixed-income capital to its funding mix. Coming on the heels of its Paramount Group REIT and Crestline Management acquisitions, the deal underlines Rithm’s push to deepen real estate asset management and broaden its capital structure. We’ll now examine how this new preferred stock issuance, alongside the Paramount and Crestline integrations, may influence Rithm’s...

Fifth Third Bancorp (FITB) is back on investor radars after recent share price moves, with the stock closing at $48.52. That price now sits against a backdrop of mixed short term returns. See our latest analysis for Fifth Third Bancorp. That recent dip in the 1 day share price return of 1.52% and 7 day share price return of 2.53% comes after a stronger 90 day share price return of 13.05%. Meanwhile, the 1 year total shareholder return of 17.25% and 5 year total shareholder return of 82.12%...

Recently, Andersons has increased its earnings before interest and tax while keeping capital employed broadly unchanged, lifting its return on capital employed to 5.4% from prior losses. This shift suggests Andersons is extracting more profit from its existing asset base, raising questions about how it will reinvest to sustain these improved returns. We’ll now explore how Andersons’ improved return on capital employed may influence its existing investment narrative built around renewables...

Interest in Booking Holdings (BKNG) is being shaped by two Agoda updates: the launch of its AI-powered Booking Form Bot to support travelers at checkout, and reported growth in family travel searches for Vietnam. See our latest analysis for Booking Holdings. At a share price of $5,391.52, Booking Holdings has had a relatively steady year, with a 6.11% 90 day share price return and a 13.66% 1 year total shareholder return. These figures suggest momentum has been building over time as investors...

In its fiscal second quarter ended November 30, 2025, Applied Digital reported US$126.59 million in revenue, sharply higher than a year earlier, while reducing its net loss to US$19.08 million and announcing new long-term hyperscale data center leases backed by substantial debt and preferred equity funding. By pairing rapid AI-focused data center buildouts with multi-year hyperscaler contracts and a planned cloud spin-off, Applied Digital is reshaping its business model around recurring...

Piper Sandler recently downgraded BorgWarner to a more cautious rating amid broad analyst activity as the company continues its shift toward electric vehicle components alongside its combustion-vehicle parts business. This reassessment highlights how BorgWarner’s dual exposure to emerging EV platforms and legacy combustion technologies is becoming a central focus for analysts and investors. We’ll now examine how Piper Sandler’s more cautious stance during BorgWarner’s EV transition could...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

BellRing Brands (BRBR) has drawn fresh attention after recent trading, with the stock showing a 6.9% decline over the past day and double digit negative returns over the past month and past three months. See our latest analysis for BellRing Brands. With the share price now at $23.10 and a 30 day share price return of 27.7% decline alongside a 1 year total shareholder return of 67.7% decline, recent weakness suggests momentum has been fading as investors reassess growth prospects and risk. If...

GameStop recently approved a massive performance-based stock option package for CEO Ryan Cohen, tied to ambitious market capitalization and EBITDA milestones, while also announcing the closure of about 296 stores to streamline its brick-and-mortar footprint. This combination of aggressive cost-cutting and an incentive plan that could be worth up to US$35 billion underscores management’s commitment to tying leadership rewards directly to long-term financial outcomes. Next, we’ll examine how...

Teradyne recently reported third-quarter fiscal 2025 results with revenue and non-GAAP earnings per share near the upper end of its guidance, while issuing strong fourth-quarter revenue and earnings forecasts supported by ongoing demand for its automated test equipment and robotics. The company’s positioning in AI-related semiconductor testing and advanced robotics, reinforced by robust institutional interest, highlights how its test and automation tools are increasingly embedded in the...

Redwire Corporation recently retired the Edge Autonomy brand, reorganized into two segments spanning space and defense technologies, and earlier this month completed payload integration for the European Space Agency’s Syndeo-3 mission using its Hammerhead LEO platform and ADPMS-3 avionics. Together, the brand unification and ESA milestone highlight Redwire’s effort to present a clearer two-segment business model while reinforcing its role as a prime contractor in European space...

Spyre Therapeutics (SYRE) is back on investor radar after management outlined six planned proof of concept readouts for 2026 and reported faster enrollment in its SKYLINE ulcerative colitis trial, alongside appointing experienced commercial leader Kate Tansey Chevlen as CCO. See our latest analysis for Spyre Therapeutics. The share price has reacted quickly to the clinical and leadership updates, with a 1-day share price return of 7.15% and a 90-day share price return of 47.81%. The 1-year...

Neogen Corporation recently reported past second-quarter fiscal 2026 results showing revenue of US$224.69 million versus US$231.26 million a year earlier, with the quarterly net loss shrinking to US$15.92 million and first-half fiscal net income reaching US$20.41 million. The company also raised its full-year 2026 revenue outlook to US$845 million–US$855 million and outlined cost-saving initiatives, portfolio divestitures, and new senior leadership appointments to reshape its Food Safety...